Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMGY51F)

Drug Name
ReN-1826 Drug Info
Synonyms Neurotrophin receptor program, Enact; Neurotrophin receptor program, ReNeuron
Indication
Disease Entry ICD 11 Status REF
Central nervous system disease 8A04-8D87 Terminated [1]
Cross-matching ID
TTD Drug ID
DMGY51F

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Neurotrophin-3 (NTF3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NT-3 DMGZ3DR Constipation DD91.1 Discontinued in Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neurotrophin-3 (NTF3) TTZHKV9 NTF3_HUMAN Inhibitor [2]
Neurotrophin-4 (NTF4) TTIM2WO NTF4_HUMAN Inhibitor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017722)
2 Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J Allergy Clin Immunol. 2006 Sep;118(3):597-605.
3 NT-3. Takeda/Regeneron/Amgen. IDrugs. 2001 Jul;4(7):820-4.